Agenus has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings. The average price target for Agenus is $39.00.
People also ask
What is the prediction for AGEN stock in 2025?
Why is Agenus stock dropping?
What is the price target for Agenus?
Who owns AGEN stock?
$12.35
Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good. Our testing substantiates this with the optimum range ...
Rating
· Review by StockInvest.us
Is Agenus Inc. stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying ...
The latest Agenus stock prices, stock quotes, news, and AGEN history to help you invest and trade smarter.
Agenus currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual ...
Rating
(2)
Agenus Stock Forecast FAQ. Is Agenus Stock a good buy in 2024, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: ...
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
According to analysts, AGEN price target is 44.25 USD with a max estimate of 60.00 USD and a min estimate of 35.00 USD. Check if this forecast comes true in a ...
Apr 8, 2024 · A buy now? There's a chance that Agenus, or one of its partners will report trial results that rescue its beaten-down stock price in 2024. That ...
The consensus rating for Agenus is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AGEN compares to other ...